Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis [Case study]

Mycobacterium tuberculosis strains resistant to almost all available anti-tuberculosis drugs are an increasing threat to public health worldwide. Among existing drugs with potential antimycobacterial effects, the combination of meropenem with clavulanate has been shown to have potent in vitro bacter...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The international journal of tuberculosis and lung disease 2012-04, Vol.16 (4), p.558-560
Hauptverfasser:	Payen, M. C., De Wit, S., Martin, C., Sergysels, R., Muylle, I., Van Laethem, Y., Clumeck, N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Antitubercular Agents - administration & dosage Antitubercular Agents - therapeutic use Bacterial diseases Biological and medical sciences Carbapenems Plus Clavulanate Clavulanic Acid - administration & dosage Clavulanic Acid - therapeutic use Drug Therapy, Combination Extensively Drug-Resistant Tuberculosis Extensively Drug-Resistant Tuberculosis - drug therapy Extensively Drug-Resistant Tuberculosis - microbiology Female Human bacterial diseases Humans Infectious diseases Male Medical sciences Microbial Sensitivity Tests Middle Aged Mycobacterium tuberculosis Mycobacterium tuberculosis - drug effects Pharmacology. Drug treatments Pneumology Respiratory system : syndromes and miscellaneous diseases Salvage Therapy Salvage Therapy - methods Severity of Illness Index Thienamycins - administration & dosage Thienamycins - therapeutic use Treatment Outcome Tuberculosis and atypical mycobacterial infections Tuberculosis, Pulmonary - drug therapy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!